182 related articles for article (PubMed ID: 11141722)
1. Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review.
D'Aprile M; Santini D; Di Cosimo S; Gravante G; Vincenzi B; Spoto S; Costantino S; Rabitti C; Tonini G
Clin Ter; 2000; 151(5):371-4. PubMed ID: 11141722
[TBL] [Abstract][Full Text] [Related]
2. [Prostatic carcinoma in a young adult: a case report].
Yamamoto S; Senzaki A; Yamagiwa K; Tanaka T; Oda T
Hinyokika Kiyo; 1990 May; 36(5):617-22. PubMed ID: 1698013
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients.
Birtle AJ; Freeman A; Masters JR; Payne HA; Harland SJ;
Cancer; 2003 Dec; 98(11):2362-7. PubMed ID: 14635070
[TBL] [Abstract][Full Text] [Related]
4. Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features. Open questions for urologists, oncologists, and infectious disease specialists.
Manfredi R; Fulgaro C; Sabbatani S; Dentale N; Legnani G
Cancer Detect Prev; 2006; 30(1):20-3. PubMed ID: 16455210
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
6. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival.
Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML
Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687
[TBL] [Abstract][Full Text] [Related]
7. [Bilateral breast metastases from prostatic carcinoma: a case report].
Soda T; Onishi H; Terachi T; Oishi K; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1999 Apr; 45(4):269-71. PubMed ID: 10363149
[TBL] [Abstract][Full Text] [Related]
8. [A case of carcinoma of the prostate presenting as abdominal mass].
Nakagawa H; Miyazaki S; Ito N
Hinyokika Kiyo; 1988 Oct; 34(10):1811-4. PubMed ID: 3072875
[TBL] [Abstract][Full Text] [Related]
9. [Prostatic carcinoma that arose with hearing loss: a case report].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jun; 53(6):413-6. PubMed ID: 17628942
[TBL] [Abstract][Full Text] [Related]
10. [Small cell carcinoma of the prostate: a case report].
Hashine K; Nakatsuji H; Karashima T; Sumiyoshi Y; Mandai K; Hata A
Hinyokika Kiyo; 1998 Aug; 44(8):607-10. PubMed ID: 9783201
[TBL] [Abstract][Full Text] [Related]
11. [A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis].
Tsuzuki M; Kawakami S; Yonese J; Ueda T; Kageyama S; Yamauchi T; Kawai T
Hinyokika Kiyo; 1994 Sep; 40(9):837-40. PubMed ID: 7801848
[TBL] [Abstract][Full Text] [Related]
12. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
[TBL] [Abstract][Full Text] [Related]
14. Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.
Cheng CW; Chan LW; Ng CF; Chan CK; Tse MK; Lai MM
Int J Urol; 2006 Apr; 13(4):463-5. PubMed ID: 16734876
[TBL] [Abstract][Full Text] [Related]
15. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
Montgomery RB; Nelson PS; Lin D; Ryan CW; Garzotto M; Beer TM
Cancer; 2007 Sep; 110(5):996-1002. PubMed ID: 17639587
[TBL] [Abstract][Full Text] [Related]
16. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
[TBL] [Abstract][Full Text] [Related]
17. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
18. [A case of primary transitional cell carcinoma of the prostate].
Morikawa H; Cho M; Takada S; Fujimoto K; Uemura H; Ozono S; Hirao Y; Natsume O
Hinyokika Kiyo; 2003 Jun; 49(6):357-60. PubMed ID: 12894737
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer with penile metastasis: a case report].
Sawada A; Segawa T; Nakanishi S; Kinoshita H; Yamamoto S; Kamoto T; Ogawa O
Hinyokika Kiyo; 2005 Nov; 51(11):771-3. PubMed ID: 16363713
[TBL] [Abstract][Full Text] [Related]
20. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
